Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1938 1
1950 2
1951 3
1953 1
1954 2
1955 3
1956 3
1957 3
1958 4
1959 7
1960 6
1961 7
1962 12
1963 17
1964 19
1965 22
1966 33
1967 24
1968 29
1969 24
1970 26
1971 25
1972 38
1973 38
1974 52
1975 40
1976 52
1977 42
1978 55
1979 56
1980 56
1981 58
1982 95
1983 83
1984 122
1985 126
1986 128
1987 143
1988 156
1989 148
1990 160
1991 145
1992 160
1993 169
1994 173
1995 224
1996 198
1997 192
1998 232
1999 244
2000 273
2001 228
2002 241
2003 219
2004 247
2005 267
2006 279
2007 298
2008 332
2009 331
2010 350
2011 343
2012 402
2013 463
2014 418
2015 408
2016 413
2017 409
2018 446
2019 519
2020 610
2021 622
2022 580
2023 515
2024 157

Text availability

Article attribute

Article type

Publication date

Search Results

11,928 results

Results by year

Filters applied: . Clear all
Page 1
A phase 1 trial of NY-ESO-1-specific TCR-engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma.
Ishihara M, Nishida Y, Kitano S, Kawai A, Muraoka D, Momose F, Harada N, Miyahara Y, Seo N, Hattori H, Takada K, Emori M, Kakunaga S, Endo M, Matsumoto Y, Sasada T, Sato E, Yamada T, Matsumine A, Nagata Y, Watanabe T, Kageyama S, Shiku H. Ishihara M, et al. Among authors: yamada t. Int J Cancer. 2023 Jun 15;152(12):2554-2566. doi: 10.1002/ijc.34453. Epub 2023 Feb 17. Int J Cancer. 2023. PMID: 36727538 Clinical Trial.
TEAD1 trapping by the Q353R-Lamin A/C causes dilated cardiomyopathy.
Yamada S, Ko T, Ito M, Sassa T, Nomura S, Okuma H, Sato M, Imasaki T, Kikkawa S, Zhang B, Yamada T, Seki Y, Fujita K, Katoh M, Kubota M, Hatsuse S, Katagiri M, Hayashi H, Hamano M, Takeda N, Morita H, Takada S, Toyoda M, Uchiyama M, Ikeuchi M, Toyooka K, Umezawa A, Yamanishi Y, Nitta R, Aburatani H, Komuro I. Yamada S, et al. Among authors: yamada t. Sci Adv. 2023 Apr 14;9(15):eade7047. doi: 10.1126/sciadv.ade7047. Epub 2023 Apr 14. Sci Adv. 2023. PMID: 37058558 Free PMC article.
Lenvatinib recruits cytotoxic GZMK+CD8 T cells in hepatocellular carcinoma.
Yamada T, Fujiwara N, Kubota N, Matsushita Y, Nakatsuka T, Kurosaki S, Minami T, Tateishi R, Ichida A, Arita J, Hasegawa K, Koike K, Fujishiro M, Nakagawa H. Yamada T, et al. Hepatol Commun. 2023 Jul 17;7(8):e0209. doi: 10.1097/HC9.0000000000000209. eCollection 2023 Aug 1. Hepatol Commun. 2023. PMID: 37471053 Free PMC article.
Tracheal leiomyoma.
Watanabe A, Fujii M, Sano T, Ikegami S, Kamei J, Kojima S, Satake Y, Yamada T. Watanabe A, et al. Among authors: yamada t. QJM. 2023 Jul 28;116(7):563-565. doi: 10.1093/qjmed/hcad044. QJM. 2023. PMID: 36944268 No abstract available.
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Miyazaki K, Sakai R, Iwaki N, Yamamoto G, Murayama K, Nishikori M, Sunami K, Yoshida I, Yano H, Takahashi N, Okamoto A, Munemoto S, Sawazaki A, Suehiro Y, Fukuhara N, Wake A, Arai A, Masaki Y, Toyama K, Yokoyama A, Tsunemine H, Hasegawa Y, Matsumoto K, Yamada T, Nishimura Y, Tamaru S, Asano N, Miyawaki K, Izutsu K, Kinoshita T, Suzuki R, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: yamada t. Cancer Sci. 2023 Jun;114(6):2689-2691. doi: 10.1111/cas.15784. Epub 2023 Mar 16. Cancer Sci. 2023. PMID: 36929591 Free PMC article. Clinical Trial. No abstract available.
Prenatal diagnosis of bone dysplasias.
Nishimura G, Handa A, Miyazaki O, Tsujioka Y, Murotsuki J, Sawai H, Yamada T, Kozuma Y, Takahashi Y, Ozawa K, Pooh R, Sase M. Nishimura G, et al. Among authors: yamada t. Br J Radiol. 2023 Jul;96(1147):20221025. doi: 10.1259/bjr.20221025. Br J Radiol. 2023. PMID: 37351952 Review.
Harnessing synthetic biology to engineer organoids and tissues.
Trentesaux C, Yamada T, Klein OD, Lim WA. Trentesaux C, et al. Among authors: yamada t. Cell Stem Cell. 2023 Jan 5;30(1):10-19. doi: 10.1016/j.stem.2022.12.013. Cell Stem Cell. 2023. PMID: 36608674 Free article. Review.
Concomitant Proton Pump Inhibitor Use With Pembrolizumab Monotherapy vs Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer.
Kawachi H, Yamada T, Tamiya M, Negi Y, Goto Y, Nakao A, Shiotsu S, Tanimura K, Takeda T, Okada A, Harada T, Date K, Chihara Y, Hasegawa I, Tamiya N, Ishida M, Katayama Y, Morimoto K, Iwasaku M, Tokuda S, Kijima T, Takayama K. Kawachi H, et al. Among authors: yamada t. JAMA Netw Open. 2023 Jul 3;6(7):e2322915. doi: 10.1001/jamanetworkopen.2023.22915. JAMA Netw Open. 2023. PMID: 37432682 Free PMC article.
11,928 results
You have reached the last available page of results. Please see the User Guide for more information.